Types of Myocardial Infarction
Myocardial infarction is classified into five distinct mechanistic types (Types 1-5) based on underlying pathophysiology, and separately categorized by ECG pattern into STEMI versus NSTEMI, with further subdivision into Q-wave versus non-Q-wave MI. 1
Mechanistic Classification (Universal Definition)
Type 1 MI: Spontaneous MI
- Mechanism: Atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection causing intraluminal thrombus
- Results in decreased myocardial blood flow or distal platelet emboli with myocyte necrosis
- Most patients have severe CAD, but 5-20% may have non-obstructive or no CAD at angiography (particularly women) 1
- This is the "classic" MI from coronary thrombosis
Type 2 MI: Supply-Demand Mismatch
- Mechanism: Myocardial injury from oxygen supply-demand imbalance where a condition other than CAD is the primary cause
- Common triggers include:
- Coronary vasospasm or endothelial dysfunction
- Coronary embolism
- Tachyarrhythmias or bradyarrhythmias
- Severe anemia
- Respiratory failure
- Hypotension or severe hypertension (with or without LVH)
- High circulating catecholamines in critically ill patients or major non-cardiac surgery 1
Type 3 MI: Sudden Cardiac Death
- Mechanism: Cardiac death with ischemic symptoms and presumed new ischemic ECG changes or new LBBB
- Death occurs before biomarkers can be obtained or rise
- Diagnosed retrospectively based on clinical presentation and ECG findings despite lacking biomarker confirmation 1
Type 4 MI: PCI-Related
- Diagnostic criteria: Troponin elevation >5× the 99th percentile upper reference limit in patients with normal baseline values
- OR troponin rise >20% if baseline values are elevated but stable
- Plus one of the following:
- New ischemic ECG changes or new LBBB
- Angiographic loss of patency of major coronary artery
- Persistent slow-flow or no-flow or embolization
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality 1
Type 4b (Stent Thrombosis): Detected by angiography or autopsy with rise/fall of biomarkers above 99th percentile 1
Type 5 MI: CABG-Related
- Diagnostic criteria: Troponin elevation >10× the 99th percentile upper reference limit in patients with normal baseline values
- Plus one of the following:
- New pathological Q waves or new LBBB
- Angiographic documented new graft or native coronary artery occlusion
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality 1
ECG Pattern Classification
STEMI (ST-Elevation MI)
- Definition: Chest discomfort or ischemic symptoms with ST elevation in two contiguous leads 1
- Diagnostic thresholds for ST elevation:
- ≥0.25 mV in men <40 years in leads V2-V3
- ≥0.2 mV in men ≥40 years in leads V2-V3
- ≥0.15 mV in women in leads V2-V3
- ≥0.1 mV in all other leads 1
- Indicates need for immediate reperfusion therapy
NSTEMI (Non-ST-Elevation MI)
- Definition: Patients without ST elevation at presentation but with elevated biomarkers
- May show new horizontal or down-sloping ST depression ≥0.05 mV in two contiguous leads and/or T-wave inversion >0.1 mV in two contiguous leads 1
- Critical caveat: 25-34% of NSTEMI cases may involve acute coronary occlusion despite lacking ST elevation 2
Q-Wave vs Non-Q-Wave MI
- Many patients develop pathological Q waves (Q-wave MI) during evolution
- Others do not develop Q waves (non-Q-wave MI)
- This distinction has prognostic implications but is less emphasized in acute management compared to STEMI/NSTEMI classification 1
Important Clinical Pitfalls
ECG limitations in critically ill patients: Recent data shows ECG features alone provide limited utility for differentiating Type 1 from Type 2 MI in ICU patients, with modest discrimination (AUC 0.73). QTc prolongation is highly prevalent in Type 2 MI (66.2% vs 52.9%) but ST elevation remains more specific for Type 1 MI 3. Always interpret ECG within the broader clinical context.
Dynamic nature of ECG changes: The ECG pattern changes over time and differs when recorded during symptoms versus after resolution. Serial ECGs at 15-30 minute intervals are essential when initial ECG is non-diagnostic 1. Pre-discharge ECG should be obtained as baseline for future comparison.
Atypical presentations: MI may occur without typical symptoms in women, elderly, diabetics, post-operative and critically ill patients—requiring heightened vigilance for rising/falling biomarker patterns even with minimal symptoms 1